PATENT CLAIM ANALYSIS

Application Number: 15988202
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "452000"]

Abstract:
The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a diffusion-controlled inner coating and an enteric outer coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Claim (Index 5):
The oral dosage form of  claim 1 , wherein less than 10% of the cholestyramine is released after 6 hours at pH of 5.5 as measured using the USP Dissolution Apparatus 2 (paddle) Ph. Eur. 2.9.3.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 93.0
- Lexical Diversity: 1.42105
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15988281', '15449781', '15988560', '15449645', '11804259']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7803624814077594
- 35 USC 102 Novelty (BERT): 0.6419626367835053
- Combined Prediction Score: 0.766522496945334
- Mean Citation Score: 409.188798
- Max Citation Score: 651.2709
- Similarity Product: 516.7526022644877

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test